Daesung Microbiological Labs. Co. Ltd (036480) — Cash Flow Quality Index
Daesung Microbiological Labs. Co. Ltd (036480) has a Cash Flow Quality Index of 4.00x as of December 2025. Operating cash flow of ₩972.26 Million exceeds net income of ₩243.19 Million, indicating high earnings quality where cash backs reported profits. Explore Daesung Microbiological Labs. Co. Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Daesung Microbiological Labs. Co. Ltd Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Daesung Microbiological Labs. Co. Ltd (036480) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year earnings quality comparison for Daesung Microbiological Labs. Co. Ltd. For live market cap and the full company financial profile, see Daesung Microbiological Labs. Co. Ltd (036480) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | ₩1.41 Billion | ₩598.19 Million | ▲ +247.5% |
| 2022 | 0.68x | ₩1.16 Billion | ₩1.70 Billion | ▼ -73.3% |
| 2021 | 2.54x | ₩2.20 Billion | ₩865.92 Million | ▲ +19.4% |
| 2020 | 2.13x | ₩3.24 Billion | ₩1.52 Billion | ▲ +162.3% |
| 2019 | 0.81x | ₩2.32 Billion | ₩2.85 Billion | ▼ -17.9% |
| 2018 | 0.99x | ₩3.14 Billion | ₩3.17 Billion | ▼ -8.3% |
| 2017 | 1.08x | ₩1.68 Billion | ₩1.56 Billion | ▲ +37.7% |
| 2016 | 0.78x | ₩3.52 Billion | ₩4.49 Billion | ▼ -53.5% |
| 2015 | 1.68x | ₩7.66 Billion | ₩4.55 Billion | ▼ -10.3% |
| 2014 | 1.88x | ₩3.83 Billion | ₩2.04 Billion | ▼ -57.0% |
| 2013 | 4.36x | ₩1.89 Billion | ₩433.00 Million | ▼ -16.6% |
| 2012 | 5.23x | ₩2.33 Billion | ₩446.00 Million | — |